Skip to content

What are the benefits of montelukast tablets?

4 min read

With millions of prescriptions dispensed annually, montelukast is a widely used medication for various respiratory conditions. This article will explore what are the benefits of montelukast tablets, highlighting their role in managing chronic asthma, allergic rhinitis, and exercise-induced breathing difficulties.

Quick Summary

Montelukast is an oral leukotriene receptor antagonist used to manage chronic asthma symptoms, relieve seasonal and perennial allergic rhinitis, and prevent exercise-induced bronchoconstriction.

Key Points

  • Long-Term Asthma Control: Montelukast acts as a daily controller medication to prevent chronic asthma symptoms like wheezing and coughing, but it is not a rescue inhaler for acute attacks.

  • Allergy Symptom Relief: It effectively reduces symptoms of both seasonal (hay fever) and perennial (year-round) allergic rhinitis, such as sneezing, congestion, and a runny nose.

  • Prevention of Exercise-Induced Asthma: Taking a dose at least two hours before physical activity can prevent breathing difficulties in individuals with exercise-induced bronchoconstriction.

  • Oral Administration: Available as a once-daily tablet, chewable tablet, or granules, montelukast offers a convenient oral alternative for symptom management, especially compared to inhaled steroids.

  • Anti-Inflammatory Action: It works by blocking leukotrienes, chemicals in the body that cause inflammation and tightening of the airways, thereby addressing the underlying cause of symptoms.

  • Neuropsychiatric Risk: A serious side effect of montelukast includes a boxed warning for potential neuropsychiatric events like depression, anxiety, and suicidal thoughts, necessitating close monitoring.

In This Article

How Montelukast Works

Montelukast, commonly known by the brand name Singulair, belongs to a class of medications called leukotriene receptor antagonists (LTRAs). When a person with asthma or allergies is exposed to a trigger, their body releases inflammatory chemicals called leukotrienes. These leukotrienes bind to receptors in the airways and nose, causing inflammation, swelling, and mucus production. In the lungs, this leads to bronchoconstriction, a narrowing of the airways that causes symptoms like wheezing and chest tightness.

Montelukast works by blocking the action of these leukotrienes. By binding to the leukotriene receptors, it prevents the inflammatory response from occurring, which helps to relax the smooth muscles in the airways and reduce mucus secretion. This mechanism of action makes it a valuable preventative medication for long-term symptom control rather than a rescue medication for an acute attack.

Primary Benefits of Montelukast Tablets

Montelukast's primary benefits revolve around its ability to provide long-term, non-steroid-based control for several respiratory and allergic conditions. Unlike inhalers, it is taken as a once-daily tablet, which can improve adherence for many patients.

Asthma Management

For individuals with chronic asthma, montelukast serves as a daily controller medication, helping to reduce the frequency and severity of asthma symptoms. It is often prescribed for mild to moderate persistent asthma, though it is not a replacement for faster-acting rescue inhalers during an asthma attack. By decreasing inflammation, montelukast helps to prevent wheezing, coughing, and chest tightness. For children under 5, it is sometimes used as an alternative therapy to inhaled corticosteroids (ICS) for milder forms of asthma.

Allergic Rhinitis Relief

Montelukast is effective in treating the symptoms of allergic rhinitis, including both seasonal (hay fever) and perennial (year-round) allergies. By blocking the effects of leukotrienes, it helps relieve symptoms such as:

  • Sneezing
  • A runny or stuffy nose
  • Nasal itching and congestion
  • Itchy, watery eyes

It is important to note that for allergic rhinitis, montelukast is often considered a second-line treatment, reserved for patients who have not responded adequately to, or cannot tolerate, alternative allergy medications due to its risk of neuropsychiatric adverse effects.

Preventing Exercise-Induced Bronchoconstriction

For many people with asthma, intense physical activity can trigger a flare-up of symptoms, a condition known as exercise-induced bronchoconstriction (EIB). Montelukast can be taken at least two hours before exercise to help prevent these breathing difficulties. This allows individuals to engage in physical activities with greater comfort and confidence.

Other Potential Uses

In some cases, montelukast is used off-label to treat other conditions. For example, it may be prescribed for chronic hives (urticaria) that last for more than six weeks, although this is not one of its primary indications.

Montelukast vs. Inhaled Corticosteroids

Montelukast is often compared to inhaled corticosteroids (ICS), which are the gold-standard treatment for many people with asthma. Here is a comparison of these two medication types:

Feature Montelukast Inhaled Corticosteroids (ICS)
Mechanism Oral leukotriene receptor antagonist Inhaled steroid that reduces inflammation
Administration Once-daily oral tablet, chewable tablet, or granules Inhaled directly into the lungs via a device
Primary Use (Asthma) A controller medication, often for mild to moderate persistent asthma, or as an add-on therapy A first-line controller medication for most people with persistent asthma
Efficacy Less effective than ICS for reducing asthma exacerbations, especially in moderate to severe cases More effective than montelukast for overall asthma control and reducing exacerbations
Adverse Effects Potential for neuropsychiatric side effects, including mood changes. Also headaches, stomach pain. Primary local side effects include throat irritation or oral thrush. Concerns about systemic effects, though generally minimal at low doses.

Important Considerations and Side Effects

While montelukast offers many benefits, it is crucial to be aware of potential side effects, particularly the boxed warning regarding neuropsychiatric events.

  • Serious Neuropsychiatric Events: The FDA requires a boxed warning on montelukast, alerting patients and healthcare providers to the risk of serious mental health changes. Patients should immediately contact their doctor if they experience agitation, aggression, depression, anxiety, hallucinations, memory problems, sleep disturbances, or suicidal thoughts. These effects can occur even in patients with no prior mental health history.

  • Common Side Effects: Less serious but more common side effects include headache, stomach pain, sore throat, cough, and diarrhea. These often resolve with continued use.

  • Monitoring: Patients taking montelukast should be monitored for any unusual changes in mood or behavior. The prescribing information includes a medication guide to inform patients of these risks.

Conclusion

Montelukast tablets offer significant benefits for individuals managing chronic asthma, allergic rhinitis, and exercise-induced bronchoconstriction. By targeting and blocking leukotrienes, it provides a preventative, non-steroidal approach to reducing inflammation and controlling symptoms. Its once-daily oral administration can simplify treatment for some patients. However, its use requires careful consideration of the potential for neuropsychiatric side effects, particularly in cases of mild allergic rhinitis where alternative therapies may be safer. Patients should always work closely with their healthcare provider to weigh the benefits and risks and determine if montelukast is the right choice for their condition.

More Information

For more detailed prescribing information, including the full FDA safety warning, you can visit the official FDA website regarding montelukast.

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any decisions about your health or treatment.

Frequently Asked Questions

No, montelukast is not a steroid. It is a leukotriene receptor antagonist, which works by a different mechanism to reduce inflammation and relax the airways.

For asthma, it is typically taken once a day in the evening. For allergic rhinitis, it can be taken at any time of day, but should be taken at roughly the same time every day for consistency.

No, montelukast is not for treating a sudden asthma attack. It is a long-term controller medication. A fast-acting rescue inhaler, as prescribed by your doctor, should be used for acute attacks.

If you miss a dose, skip it and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.

The boxed warning highlights the risk of serious neuropsychiatric events, including depression, anxiety, and suicidal thoughts. Patients experiencing unusual mood or behavior changes should contact their doctor immediately.

Montelukast starts working immediately, but it takes several weeks of consistent use to see the full benefits for asthma control. It is important to continue taking it even when you feel well.

Yes, montelukast is often a second-line treatment for allergic rhinitis. Other options include antihistamines and nasal corticosteroids. Its use for mild allergies is generally reserved for those who cannot tolerate or do not respond to other therapies due to the risk of side effects.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.